ATP-driven bioluminescence predicts children at high risk for tooth decay: OHSU study The study.

Untreated, many cariogenic bacteria adhere to teeth and breakdown the protecting enamel covering, leading to lesions and cavities. There exists a critical want in dentistry to develop better quantitative assessment options for oral hygiene and to determine individual risk for dental care caries, because disease and also restorative treatment results in the irreversible lack of tooth structure. Prior caries risk assessments have focused on social, behavioral, microbiologic, clinical and environmental variables. Related StoriesOCD individuals can reap the benefits of exposure and response avoidance therapy when drug treatment options failNew research examines previously unknown top secret to DNA repairFour types of gut bacterias can protect infants from asthmaThe goal of the OHSU study was to examine the usage of microbiological testing, specifically ATP-driven bioluminescence, for quantifying oral bacterias, including plaque streptococci, and evaluation of oral hygiene and caries risk.Spiegel, MD, the Marilyn and Stanley M. Katz Dean of Einstein. ‘This collaboration is certainly paramount in our efforts to really improve health outcomes.’ ANY OFFICE of Clinical Trials is located on the eighth flooring of the Moses Research Tower on the Moses Campus, and on the fifth floor of the Mazer building on the Einstein Campus.

Actinium completes Actimab-A Phase I/II research on Acute Myeloid Leukemia Actinium Pharmaceuticals, Inc. Patients were treated at Memorial Sloan Kettering Tumor Center in NEW YORK. Dragan Cicic, the CEO of Actinium Pharmaceuticals. ‘We are looking towards accelerated accrual and timely completion of the existing trial and moving into Phase II as prepared.

Copyright blindserver.com 2017